▶ 調査レポート

世界の安定同位体標識生体分子産業2020-2026

• 英文タイトル:Global Stable Isotope Labeled Biomolecules Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが調査・発行した産業分析レポートです。世界の安定同位体標識生体分子産業2020-2026 / Global Stable Isotope Labeled Biomolecules Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 / D0MA3013184資料のイメージです。• レポートコード:D0MA3013184
• 出版社/出版日:QYResearch / 2020年1月
• レポート形態:英文、PDF、116ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥553,700 (USD4,900)▷ お問い合わせ
  Multi User¥830,550 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,107,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、安定同位体標識生体分子の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、安定同位体標識生体分子のグローバル市場動向、メーカー別競争状況、種類別市場規模(D標識生体分子、15N標識生体分子、13C標識生体分子、その他)、用途別市場規模(科学研究、医療、工業、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。
・レポート概要
・グローバル市場動向
・メーカー別競争状況
・安定同位体標識生体分子の種類別市場2015-2026:D標識生体分子、15N標識生体分子、13C標識生体分子、その他
・安定同位体標識生体分子の用途別市場2015-2026:科学研究、医療、工業、その他
・安定同位体標識生体分子の北米市場分析
・安定同位体標識生体分子のアジア市場分析
・安定同位体標識生体分子の中南米市場分析
・安定同位体標識生体分子の中東・アフリカ市場分析
・関連企業情報:Cambridge Isotope Laboratories、Sigma-Aldrich、Thermo Fisher Scientific、LGC Standards、Toronto Research Chemicals、IsoLife、WITEGA Laboratorien、Omicron Biochemicals、Icon Isotopes、Medical Isotopes
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

This report studies the Stable Isotope Labeled Biomolecules market, Stable Isotope Labeled Biomolecules refer to the biomolecule which is labeled by replacing specific atoms by their isotope, and then the reactant is then allowed to undergo the reaction.

An important tool for high-resolution structure determination for NMR spectroscopy is the use of stable isotopically labeled biomolecules. By either selectively or uniformly incorporating stable isotopes into proteins, the user is able to significantly reduce the complexity of their spectra. D Labeled Biomolecules, 15N, and deuterium are the most common isotopes incorporated into proteins. Microbial expression systems, cell-free extracts, peptide synthesis and custom synthesis provide a variety of options for accomplishing the incorporation of the labels. Microbial expression systems are cell-based protein expression systems in which the microbes are grown in either a defined or complex media with D Labeled Biomolecules labeled glucoses and 15N Labeled Biomoleculeslabeled ammonium salts as the sole sources of carbon and nitrogen respectively. Ease of use, adaptability and high protein yields have made these expression systems the most popular technique for stable isotope incorporation. Cell-free extracts and custom synthesis also present their own individual advantages with the use of uniformly or selectively labeled amino acids. Cell-free extracts allow the user to more readily implement high-throughput in vitro protein expression as many proteins are difficult to express in vivo due to complications such as toxicity. Custom synthesis allows for unique, site-specific incorporation of isotopes into peptides allowing the user to study distinct structural regions.
North America is the largest consumer by regions. North America accounted about 52.63% consumption market share in 2016. Europe is the second largest with 33.92% market share. China is the following consumption region with 5.53% consumption market share.
In 2019, the global Stable Isotope Labeled Biomolecules market size was US$ 111 million and is forecast to US$ 135.9 million in 2026, growing at a CAGR of 2.9% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Stable Isotope Labeled Biomolecules.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Stable Isotope Labeled Biomolecules market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Stable Isotope Labeled Biomolecules market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Stable Isotope Labeled Biomolecules market. Readers of the report can become informed about current and future trends of the global Stable Isotope Labeled Biomolecules market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Stable Isotope Labeled Biomolecules markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Stable Isotope Labeled Biomolecules market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Stable Isotope Labeled Biomolecules market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Stable Isotope Labeled Biomolecules market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Stable Isotope Labeled Biomolecules market is segmented into
D Labeled Biomolecules
15N Labeled Biomolecules
13C Labeled Biomolecules
Others

Market Segment by Application, the Stable Isotope Labeled Biomolecules market is segmented into
Scientific Research
Medical
Industrial
Others

This report includes the following manufacturers; we can also add the other companies as you want.
Cambridge Isotope Laboratories
Sigma-Aldrich
Thermo Fisher Scientific
LGC Standards
Toronto Research Chemicals
IsoLife
WITEGA Laboratorien
Omicron Biochemicals
Icon Isotopes
Medical Isotopes

The study objectives are:
To analyze and research the global Stable Isotope Labeled Biomolecules status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Stable Isotope Labeled Biomolecules manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Stable Isotope Labeled Biomolecules are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Stable Isotope Labeled Biomolecules Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Stable Isotope Labeled Biomolecules Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 D Labeled Biomolecules
1.3.3 15N Labeled Biomolecules
1.3.4 13C Labeled Biomolecules
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Stable Isotope Labeled Biomolecules Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Scientific Research
1.4.3 Medical
1.4.4 Industrial
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Stable Isotope Labeled Biomolecules Revenue (2015-2026)
2.1.1 Global Stable Isotope Labeled Biomolecules Revenue (2015-2026)
2.1.2 Global Stable Isotope Labeled Biomolecules Sales (2015-2026)
2.2 Stable Isotope Labeled Biomolecules Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Stable Isotope Labeled Biomolecules Sales by Regions (2015-2020)
2.2.2 Global Stable Isotope Labeled Biomolecules Revenue by Regions (2015-2020)
2.3 Global Top Stable Isotope Labeled Biomolecules Regions (Countries) Ranking by Market Size
2.4 Stable Isotope Labeled Biomolecules Industry Trends
2.4.1 Stable Isotope Labeled Biomolecules Market Top Trends
2.4.2 Market Drivers
2.4.3 Stable Isotope Labeled Biomolecules Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Stable Isotope Labeled Biomolecules Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Stable Isotope Labeled Biomolecules Manufacturers by Sales (2015-2020)
3.1.1 Global Stable Isotope Labeled Biomolecules Sales by Manufacturers (2015-2020)
3.1.2 Global Stable Isotope Labeled Biomolecules Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Stable Isotope Labeled Biomolecules Sales in 2019
3.2 Global Top Manufacturers Stable Isotope Labeled Biomolecules by Revenue
3.2.1 Global Stable Isotope Labeled Biomolecules Revenue by Manufacturers (2015-2020)
3.2.2 Global Stable Isotope Labeled Biomolecules Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Stable Isotope Labeled Biomolecules Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stable Isotope Labeled Biomolecules as of 2019)
3.4 Global Stable Isotope Labeled Biomolecules Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Stable Isotope Labeled Biomolecules Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Stable Isotope Labeled Biomolecules Market
3.7 Key Manufacturers Stable Isotope Labeled Biomolecules Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Stable Isotope Labeled Biomolecules Historic Market Review by Type (2015-2020)
4.1.2 Global Stable Isotope Labeled Biomolecules Sales Market Share by Type (2015-2020)
4.1.3 Global Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2015-2020)
4.1.4 Stable Isotope Labeled Biomolecules Price by Type (2015-2020)
4.1 Global Stable Isotope Labeled Biomolecules Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Stable Isotope Labeled Biomolecules Sales Forecast by Type (2021-2026)
4.2.3 Global Stable Isotope Labeled Biomolecules Revenue Forecast by Type (2021-2026)
4.2.4 Stable Isotope Labeled Biomolecules Price Forecast by Type (2021-2026)

5 Global Stable Isotope Labeled Biomolecules Market Size by Application
5.1 Global Stable Isotope Labeled Biomolecules Historic Market Review by Application (2015-2020)
5.1.2 Global Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
5.1.3 Global Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2015-2020)
5.1.4 Stable Isotope Labeled Biomolecules Price by Application (2015-2020)
5.2 Global Stable Isotope Labeled Biomolecules Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Stable Isotope Labeled Biomolecules Sales Forecast by Application (2021-2026)
5.2.3 Global Stable Isotope Labeled Biomolecules Revenue Forecast by Application (2021-2026)
5.2.4 Stable Isotope Labeled Biomolecules Price Forecast by Application (2021-2026)

6 North America
6.1 North America Stable Isotope Labeled Biomolecules Breakdown Data by Company
6.2 North America Stable Isotope Labeled Biomolecules Breakdown Data by Type
6.3 North America Stable Isotope Labeled Biomolecules Breakdown Data by Application
6.4 North America Stable Isotope Labeled Biomolecules Breakdown Data by Countries
6.4.1 North America Stable Isotope Labeled Biomolecules Sales by Countries
6.4.2 North America Stable Isotope Labeled Biomolecules Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Stable Isotope Labeled Biomolecules Breakdown Data by Company
7.2 Europe Stable Isotope Labeled Biomolecules Breakdown Data by Type
7.3 Europe Stable Isotope Labeled Biomolecules Breakdown Data by Application
7.4 Europe Stable Isotope Labeled Biomolecules Breakdown Data by Countries
7.4.1 Europe Stable Isotope Labeled Biomolecules Sales by Countries
7.4.2 Europe Stable Isotope Labeled Biomolecules Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Stable Isotope Labeled Biomolecules Breakdown Data by Company
8.2 Asia Pacific Stable Isotope Labeled Biomolecules Breakdown Data by Type
8.3 Asia Pacific Stable Isotope Labeled Biomolecules Breakdown Data by Application
8.4 Asia Pacific Stable Isotope Labeled Biomolecules Breakdown Data by Regions
8.4.1 Asia Pacific Stable Isotope Labeled Biomolecules Sales by Regions
8.4.2 Asia Pacific Stable Isotope Labeled Biomolecules Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Stable Isotope Labeled Biomolecules Breakdown Data by Company
9.2 Latin America Stable Isotope Labeled Biomolecules Breakdown Data by Type
9.3 Latin America Stable Isotope Labeled Biomolecules Breakdown Data by Application
9.4 Latin America Stable Isotope Labeled Biomolecules Breakdown Data by Countries
9.4.1 Latin America Stable Isotope Labeled Biomolecules Sales by Countries
9.4.2 Latin America Stable Isotope Labeled Biomolecules Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Stable Isotope Labeled Biomolecules Breakdown Data by Type
10.2 Middle East and Africa Stable Isotope Labeled Biomolecules Breakdown Data by Application
10.3 Middle East and Africa Stable Isotope Labeled Biomolecules Breakdown Data by Countries
10.3.1 Middle East and Africa Stable Isotope Labeled Biomolecules Sales by Countries
10.3.2 Middle East and Africa Stable Isotope Labeled Biomolecules Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Cambridge Isotope Laboratories
11.1.1 Cambridge Isotope Laboratories Corporation Information
11.1.2 Cambridge Isotope Laboratories Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Products and Services
11.1.5 Cambridge Isotope Laboratories SWOT Analysis
11.1.6 Cambridge Isotope Laboratories Recent Developments
11.2 Sigma-Aldrich
11.2.1 Sigma-Aldrich Corporation Information
11.2.2 Sigma-Aldrich Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Sigma-Aldrich Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Sigma-Aldrich Stable Isotope Labeled Biomolecules Products and Services
11.2.5 Sigma-Aldrich SWOT Analysis
11.2.6 Sigma-Aldrich Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Corporation Information
11.3.2 Thermo Fisher Scientific Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Products and Services
11.3.5 Thermo Fisher Scientific SWOT Analysis
11.3.6 Thermo Fisher Scientific Recent Developments
11.4 LGC Standards
11.4.1 LGC Standards Corporation Information
11.4.2 LGC Standards Business Overview and Total Revenue (2019 VS 2018)
11.4.3 LGC Standards Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 LGC Standards Stable Isotope Labeled Biomolecules Products and Services
11.4.5 LGC Standards SWOT Analysis
11.4.6 LGC Standards Recent Developments
11.5 Toronto Research Chemicals
11.5.1 Toronto Research Chemicals Corporation Information
11.5.2 Toronto Research Chemicals Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Toronto Research Chemicals Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Toronto Research Chemicals Stable Isotope Labeled Biomolecules Products and Services
11.5.5 Toronto Research Chemicals SWOT Analysis
11.5.6 Toronto Research Chemicals Recent Developments
11.6 IsoLife
11.6.1 IsoLife Corporation Information
11.6.2 IsoLife Business Overview and Total Revenue (2019 VS 2018)
11.6.3 IsoLife Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 IsoLife Stable Isotope Labeled Biomolecules Products and Services
11.6.5 IsoLife SWOT Analysis
11.6.6 IsoLife Recent Developments
11.7 WITEGA Laboratorien
11.7.1 WITEGA Laboratorien Corporation Information
11.7.2 WITEGA Laboratorien Business Overview and Total Revenue (2019 VS 2018)
11.7.3 WITEGA Laboratorien Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 WITEGA Laboratorien Stable Isotope Labeled Biomolecules Products and Services
11.7.5 WITEGA Laboratorien SWOT Analysis
11.7.6 WITEGA Laboratorien Recent Developments
11.8 Omicron Biochemicals
11.8.1 Omicron Biochemicals Corporation Information
11.8.2 Omicron Biochemicals Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Omicron Biochemicals Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Omicron Biochemicals Stable Isotope Labeled Biomolecules Products and Services
11.8.5 Omicron Biochemicals SWOT Analysis
11.8.6 Omicron Biochemicals Recent Developments
11.9 Icon Isotopes
11.9.1 Icon Isotopes Corporation Information
11.9.2 Icon Isotopes Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Icon Isotopes Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Icon Isotopes Stable Isotope Labeled Biomolecules Products and Services
11.9.5 Icon Isotopes SWOT Analysis
11.9.6 Icon Isotopes Recent Developments
11.10 Medical Isotopes
11.10.1 Medical Isotopes Corporation Information
11.10.2 Medical Isotopes Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Medical Isotopes Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Medical Isotopes Stable Isotope Labeled Biomolecules Products and Services
11.10.5 Medical Isotopes SWOT Analysis
11.10.6 Medical Isotopes Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Stable Isotope Labeled Biomolecules Sales Channels
12.2.2 Stable Isotope Labeled Biomolecules Distributors
12.3 Stable Isotope Labeled Biomolecules Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Stable Isotope Labeled Biomolecules Sales Forecast (2021-2026)
13.1.1 Global Stable Isotope Labeled Biomolecules Sales Forecast by Regions (2021-2026)
13.1.2 Global Stable Isotope Labeled Biomolecules Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Stable Isotope Labeled Biomolecules Sales Forecast (2021-2026)
13.2.2 North America Stable Isotope Labeled Biomolecules Revenue Forecast (2021-2026)
13.2.3 North America Stable Isotope Labeled Biomolecules Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Stable Isotope Labeled Biomolecules Sales Forecast (2021-2026)
13.3.2 Europe Stable Isotope Labeled Biomolecules Revenue Forecast (2021-2026)
13.3.3 Europe Stable Isotope Labeled Biomolecules Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Stable Isotope Labeled Biomolecules Sales Forecast (2021-2026)
13.4.2 Asia Pacific Stable Isotope Labeled Biomolecules Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Stable Isotope Labeled Biomolecules Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Stable Isotope Labeled Biomolecules Sales Forecast (2021-2026)
13.5.2 Latin America Stable Isotope Labeled Biomolecules Revenue Forecast (2021-2026)
13.5.3 Latin America Stable Isotope Labeled Biomolecules Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Stable Isotope Labeled Biomolecules Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Stable Isotope Labeled Biomolecules Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Stable Isotope Labeled Biomolecules Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Stable Isotope Labeled Biomolecules Key Market Segments
Table 2. Ranking of Global Top Stable Isotope Labeled Biomolecules Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Stable Isotope Labeled Biomolecules Market Size Growth Rate by Type 2021-2026 (g) & (Million US$)
Table 4. Major Manufacturers of D Labeled Biomolecules
Table 5. Major Manufacturers of 15N Labeled Biomolecules
Table 6. Major Manufacturers of 13C Labeled Biomolecules
Table 7. Major Manufacturers of Others
Table 8. Global Stable Isotope Labeled Biomolecules Market Share by Application 2019-2025 (g)
Table 9. Global Stable Isotope Labeled Biomolecules Market Size by Regions 2015-2020 (g) & (Million US$)
Table 10. Global Stable Isotope Labeled Biomolecules Sales by Regions 2015-2020 (g)
Table 11. Global Stable Isotope Labeled Biomolecules Sales Market Share by Regions 2015-2020
Table 12. Global Stable Isotope Labeled Biomolecules Revenue by Regions 2015-2020 (Million US$)
Table 13. Global Stable Isotope Labeled Biomolecules Revenue Market Share by Regions 2015-2020
Table 14. Top Stable Isotope Labeled Biomolecules Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 15. Market Top Trends
Table 16. Stable Isotope Labeled Biomolecules Key Drivers: Impact Analysis (2021-2026)
Table 17. Stable Isotope Labeled Biomolecules Key Challenges
Table 18. Main Points Interviewed from Key Stable Isotope Labeled Biomolecules Players: Views for Future
Table 19. Global Stable Isotope Labeled Biomolecules Sales by Manufacturers (2015-2020) (g)
Table 20. Global Stable Isotope Labeled Biomolecules Sales Share by Manufacturers (2015-2020)
Table 21. Stable Isotope Labeled Biomolecules Revenue by Manufacturers (2015-2020) (Million US$)
Table 22. Stable Isotope Labeled Biomolecules Revenue Share by Manufacturers (2015-2020)
Table 23. Global Stable Isotope Labeled Biomolecules Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stable Isotope Labeled Biomolecules as of 2019)
Table 25. Key Manufacturers Stable Isotope Labeled Biomolecules Average Selling Price (ASP) (2015-2020) (USD/g)
Table 26. Key Manufacturers Stable Isotope Labeled Biomolecules Plants/Factories Distribution
Table 27. Key Manufacturers Stable Isotope Labeled Biomolecules Area Served
Table 28. Date of Key Manufacturers Enter into Stable Isotope Labeled Biomolecules Market
Table 29. Key Manufacturers Stable Isotope Labeled Biomolecules Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global D Labeled Biomolecules Sales and Revenue (2015-2020) (g) & (Million US$)
Table 32. Global 15N Labeled Biomolecules Sales and Revenue (2015-2020) (g) & (Million US$)
Table 33. Global 13C Labeled Biomolecules Sales ana Revenue (2015-2020) (g) & (Million US$)
Table 34. Global Others Sales ana Revenue (2015-2020) (g) & (Million US$)
Table 35. Global Stable Isotope Labeled Biomolecules Sales (g) by Type (2015-2020)
Table 36. Global Stable Isotope Labeled Biomolecules Sales Share by Type (2015-2020)
Table 37. Global Stable Isotope Labeled Biomolecules Revenue (US$ Million) Market Share by Type (2015-2020)
Table 38. Global Stable Isotope Labeled Biomolecules Price (g) by Type (2015-2020)
Table 39. Global Stable Isotope Labeled Biomolecules Sales (g) by Type (2021-2026)
Table 40. Global Stable Isotope Labeled Biomolecules Sales Share by Type (2021-2026)
Table 41. Global Stable Isotope Labeled Biomolecules Revenue (US$ Million) Market Share by Type (2021-2026)
Table 42. Global Stable Isotope Labeled Biomolecules Revenue Share by Type (2021-2026)
Table 43. Global Stable Isotope Labeled Biomolecules Price (g) by Type (2021-2026)
Table 44. Global Stable Isotope Labeled Biomolecules Sales (g) by Application (2015-2020)
Table 45. Global Stable Isotope Labeled Biomolecules Sales Share by Application (2015-2020)
Table 46. Global Stable Isotope Labeled Biomolecules Revenue (US$ Million) Market Share by Application (2015-2020)
Table 47. Global Stable Isotope Labeled Biomolecules Price by Application 2015-2020 (USD/g)
Table 48. Global Stable Isotope Labeled Biomolecules Sales by Application (2015-2020) (g)
Table 49. Global Stable Isotope Labeled Biomolecules Sales Share by Application (2015-2020)
Table 50. Global Stable Isotope Labeled Biomolecules Revenue (US$ Million) Market Share by Application (2021-2026)
Table 51. Global Stable Isotope Labeled Biomolecules Revenue Share by Application (2021-2026)
Table 52. Global Stable Isotope Labeled Biomolecules Price (g) by Application (2021-2026)
Table 53. North America Stable Isotope Labeled Biomolecules Sales by Company (2015-2020) (g)
Table 54. North America Stable Isotope Labeled Biomolecules Sales Market Share by Company (2015-2020)
Table 55. North America Stable Isotope Labeled Biomolecules Sales by Type (2015-2020) (g)
Table 56. North America Stable Isotope Labeled Biomolecules Sales Market Share by Type (2015-2020)
Table 57. North America Stable Isotope Labeled Biomolecules Sales by Application (2015-2020) (g)
Table 58. North America Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
Table 59. North America Stable Isotope Labeled Biomolecules Sales by Countries (2015-2020) (g)
Table 60. North America Stable Isotope Labeled Biomolecules Sales Market Share by Countries (2015-2020)
Table 61. North America Stable Isotope Labeled Biomolecules Revenue by Countries (2015-2020) (Million US$)
Table 62. North America Stable Isotope Labeled Biomolecules Revenue Market Share by Countries (2015-2020)
Table 63. Europe Stable Isotope Labeled Biomolecules Sales by Company (2015-2020) (g)
Table 64. Europe Stable Isotope Labeled Biomolecules Sales Market Share by Company (2015-2020)
Table 65. Europe Stable Isotope Labeled Biomolecules Sales by Type (2015-2020) (g)
Table 66. Europe Stable Isotope Labeled Biomolecules Sales Market Share by Type (2015-2020)
Table 67. Europe Stable Isotope Labeled Biomolecules Sales by Application (2015-2020) (g)
Table 68. Europe Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
Table 69. Europe Stable Isotope Labeled Biomolecules Sales by Countries (2015-2020) (g)
Table 70. Europe Stable Isotope Labeled Biomolecules Sales Market Share by Countries (2015-2020)
Table 71. Europe Stable Isotope Labeled Biomolecules Revenue by Countries (2015-2020) (Million US$)
Table 72. Europe Stable Isotope Labeled Biomolecules Revenue Market Share by Countries (2015-2020)
Table 73. Asia Pacific Stable Isotope Labeled Biomolecules Sales by Regions (2015-2020) (g)
Table 74. Asia Pacific Stable Isotope Labeled Biomolecules Sales Market Share by Regions (2015-2020)
Table 75. Asia Pacific Stable Isotope Labeled Biomolecules Sales by Type (2015-2020) (g)
Table 76. Asia Pacific Stable Isotope Labeled Biomolecules Sales Market Share by Type (2015-2020)
Table 77. Asia Pacific Stable Isotope Labeled Biomolecules Sales by Application (2015-2020) (g)
Table 78. Asia Pacific Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
Table 79. Asia Pacific Stable Isotope Labeled Biomolecules Sales by Countries (2015-2020) (g)
Table 80. Asia Pacific Stable Isotope Labeled Biomolecules Sales Market Share by Regions (2015-2020)
Table 81. Asia Pacific Stable Isotope Labeled Biomolecules Revenue by Regions (2015-2020) (Million US$)
Table 82. Asia Pacific Stable Isotope Labeled Biomolecules Revenue Market Share by Regions (2015-2020)
Table 83. Latin America Stable Isotope Labeled Biomolecules Sales by Company (2015-2020) (g)
Table 84. Latin America Stable Isotope Labeled Biomolecules Sales Market Share by Company (2015-2020)
Table 85. Latin America Stable Isotope Labeled Biomolecules Sales by Type (2015-2020) (g)
Table 86. Latin America Stable Isotope Labeled Biomolecules Sales Market Share by Type (2015-2020)
Table 87. Latin America Stable Isotope Labeled Biomolecules Sales by Application (2015-2020) (g)
Table 88. Latin America Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
Table 89. Latin America Stable Isotope Labeled Biomolecules Sales by Countries (2015-2020) (g)
Table 90. Latin America Stable Isotope Labeled Biomolecules Sales Market Share by Countries (2015-2020)
Table 91. Latin America Stable Isotope Labeled Biomolecules Revenue by Countries (2015-2020) (Million US$)
Table 92. Latin America Stable Isotope Labeled Biomolecules Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Stable Isotope Labeled Biomolecules Sales by Type (2015-2020) (g)
Table 94. Middle East and Africa Stable Isotope Labeled Biomolecules Sales Market Share by Type (2015-2020)
Table 95. Middle East and Africa Stable Isotope Labeled Biomolecules Sales by Application (2015-2020) (g)
Table 96. Middle East and Africa Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
Table 97. Middle East and Africa Stable Isotope Labeled Biomolecules Sales by Countries (2015-2020) (g)
Table 98. Middle East and Africa Stable Isotope Labeled Biomolecules Sales Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Stable Isotope Labeled Biomolecules Revenue by Countries (2015-2020) (Million US$)
Table 100. Middle East and Africa Stable Isotope Labeled Biomolecules Revenue Market Share by Countries (2015-2020)
Table 101. Cambridge Isotope Laboratories Company Details
Table 102. Cambridge Isotope Laboratories Description and Business Overview
Table 103. Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Sales (g), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 104. Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020)
Table 105. Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Sales Market Share in Global Market
Table 106. Cambridge Isotope Laboratories Recent Development
Table 107. Sigma-Aldrich Company Details
Table 108. Sigma-Aldrich Description and Business Overview
Table 109. Sigma-Aldrich Stable Isotope Labeled Biomolecules Sales (g), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 110. Sigma-Aldrich Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020)
Table 111. Sigma-Aldrich Stable Isotope Labeled Biomolecules Sales Market Share in Global Market
Table 112. Sigma-Aldrich Recent Development
Table 113. Thermo Fisher Scientific Company Details
Table 114. Thermo Fisher Scientific Description and Business Overview
Table 115. Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Sales (g), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 116. Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020)
Table 117. Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Sales Market Share in Global Market
Table 118. Thermo Fisher Scientific Recent Development
Table 119. LGC Standards Company Details
Table 120. LGC Standards Description and Business Overview
Table 121. LGC Standards Stable Isotope Labeled Biomolecules Sales (g), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 122. LGC Standards Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020)
Table 123. LGC Standards Stable Isotope Labeled Biomolecules Sales Market Share in Global Market
Table 124. LGC Standards Recent Development
Table 125. Toronto Research Chemicals Company Details
Table 126. Toronto Research Chemicals Description and Business Overview
Table 127. Toronto Research Chemicals Stable Isotope Labeled Biomolecules Sales (g), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 128. Toronto Research Chemicals Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020)
Table 129. Toronto Research Chemicals Stable Isotope Labeled Biomolecules Sales Market Share in Global Market
Table 130. Toronto Research Chemicals Recent Development
Table 131. IsoLife Company Details
Table 132. IsoLife Description and Business Overview
Table 133. IsoLife Stable Isotope Labeled Biomolecules Sales (g), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 134. IsoLife Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020)
Table 135. IsoLife Stable Isotope Labeled Biomolecules Sales Market Share in Global Market
Table 136. IsoLife Recent Development
Table 137. WITEGA Laboratorien Company Details
Table 138. WITEGA Laboratorien Description and Business Overview
Table 139. WITEGA Laboratorien Stable Isotope Labeled Biomolecules Sales (g), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 140. WITEGA Laboratorien Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020)
Table 141. WITEGA Laboratorien Stable Isotope Labeled Biomolecules Sales Market Share in Global Market
Table 142. WITEGA Laboratorien Recent Development
Table 143. Omicron Biochemicals Company Details
Table 144. Omicron Biochemicals Description and Business Overview
Table 145. Omicron Biochemicals Stable Isotope Labeled Biomolecules Sales (g), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 146. Omicron Biochemicals Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020)
Table 147. Omicron Biochemicals Stable Isotope Labeled Biomolecules Sales Market Share in Global Market
Table 148. Omicron Biochemicals Recent Development
Table 149. Icon Isotopes Company Details
Table 150. Icon Isotopes Description and Business Overview
Table 151. Icon Isotopes Stable Isotope Labeled Biomolecules Sales (g), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 152. Icon Isotopes Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020)
Table 153. Icon Isotopes Stable Isotope Labeled Biomolecules Sales Market Share in Global Market
Table 154. Icon Isotopes Recent Development
Table 155. Medical Isotopes Company Details
Table 156. Medical Isotopes Description and Business Overview
Table 157. Medical Isotopes Stable Isotope Labeled Biomolecules Sales (g), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 158. Medical Isotopes Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020)
Table 159. Medical Isotopes Stable Isotope Labeled Biomolecules Sales Market Share in Global Market
Table 160. Medical Isotopes Recent Development
Table 161. Stable Isotope Labeled Biomolecules Distributors List
Table 162. Stable Isotope Labeled Biomolecules Customers List
Table 163. Global Stable Isotope Labeled Biomolecules Sales Forecast 2021-2026 (g) & (Million US$)
Table 164. Global Stable Isotope Labeled Biomolecules Sales Forecast by Type 2021-2026 (g)
Table 165. Global Stable Isotope Labeled Biomolecules Sales Forecast by Application 2021-2026 (g)
Table 166. Global Stable Isotope Labeled Biomolecules Sales Forecast by Regions 2021-2026 (g)
Table 167. Global Stable Isotope Labeled Biomolecules Revenue Forecast by Regions 2021-2026 (Million US$)
Table 168. North America Stable Isotope Labeled Biomolecules Sales Forecast by Countries 2021-2026 (g)
Table 169. North America Stable Isotope Labeled Biomolecules Revenue Forecast by Countries 2021-2026
Table 170. Europe Stable Isotope Labeled Biomolecules Sales Forecast by Countries 2021-2026 (g)
Table 171. Europe Stable Isotope Labeled Biomolecules Revenue Market Share Forecast by Countries 2021-2026
Table 172. Asia Pacific Stable Isotope Labeled Biomolecules Sales Forecast by Regions 2021-2026 (g)
Table 173. Asia Pacific Stable Isotope Labeled Biomolecules Revenue Forecast by Regions 2021-2026 (Million US$)
Table 174. Latin America Stable Isotope Labeled Biomolecules Sales Forecast by Countries 2021-2026 (g)
Table 175. Latin America Stable Isotope Labeled Biomolecules Revenue Forecast by Countries 2021-2026 (Million US$)
Table 176. Middle East and Africa Stable Isotope Labeled Biomolecules Sales Forecast by Regions 2021-2026 (g)
Table 177. Middle East and Africa Stable Isotope Labeled Biomolecules Revenue Forecast by Regions 2021-2026 (Million US$)
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Stable Isotope Labeled Biomolecules Product Picture
Figure 2. Global Stable Isotope Labeled Biomolecules Sales Market Shar by Type 2015-2026
Figure 3. D Labeled Biomolecules Figures
Figure 4. 15N Labeled Biomolecules Figures
Figure 5. 13C Labeled Biomolecules Figures
Figure 6. Others Figures
Figure 7. Global Stable Isotope Labeled Biomolecules Sales Market Share by Application in 2019 & 2026
Figure 8. Scientific Research Use Case
Figure 9. Medical Use Case
Figure 10. Industrial Use Case
Figure 11. Others Use Case
Figure 12. Stable Isotope Labeled Biomolecules Report Years Considered
Figure 13. Global Stable Isotope Labeled Biomolecules Market Size 2015-2026 (Million US$)
Figure 14. Global Stable Isotope Labeled Biomolecules Sales 2015-2020 (g)
Figure 15. Global Stable Isotope Labeled Biomolecules Market Size Market Share by Regions 2015-2020
Figure 16. Global Stable Isotope Labeled Biomolecules Sales Market Share by Regions in 2019
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Stable Isotope Labeled Biomolecules Sales Share by Manufacturers in 2019
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Stable Isotope Labeled Biomolecules Sales in 2019
Figure 20. Stable Isotope Labeled Biomolecules Value Share by Manufacturers in 2019
Figure 21. Stable Isotope Labeled Biomolecules Revenue Share by Manufacturers In 2019
Figure 22. Stable Isotope Labeled Biomolecules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Stable Isotope Labeled Biomolecules Revenue Share by Type (2015-2020)
Figure 24. Global Stable Isotope Labeled Biomolecules Revenue Growth Rate by Type in 2015 & 2019
Figure 25. Global Stable Isotope Labeled Biomolecules Market Share by Price Range (2015-2020)
Figure 26. Global Stable Isotope Labeled Biomolecules Revenue Share by Application (2015-2020)
Figure 27. Global Stable Isotope Labeled Biomolecules Revenue Growth Rate by Application in 2015 & 2019
Figure 28. North America Stable Isotope Labeled Biomolecules Revenue Growth Rate 2015-2020 (Million US$)
Figure 29. U.S. Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 30. Canada Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 31. Europe Stable Isotope Labeled Biomolecules Revenue Growth Rate 2015-2020 (Million US$)
Figure 32. Germany Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 33. France Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 34. U.K. Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 35. Italy Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 36. Russia Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 37. Asia Pacific Stable Isotope Labeled Biomolecules Revenue Growth Rate 2015-2020 (Million US$)
Figure 38. China Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 39. Japan Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 40. South Korea Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 41. India Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 42. Australia Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 43. Taiwan Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 44. Indonesia Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 45. Thailand Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 46. Malaysia Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 47. Philippines Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 48. Vietnam Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 49. Latin America Stable Isotope Labeled Biomolecules Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Mexico Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 51. Brazil Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 52. Argentina Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 53. Middle East and Africa Stable Isotope Labeled Biomolecules Revenue Growth Rate 2015-2020 (Million US$)
Figure 54. Turkey Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 55. Saudi Arabia Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 56. U.A.E Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (g)
Figure 57. Cambridge Isotope Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Sigma-Aldrich Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. LGC Standards Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Toronto Research Chemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. IsoLife Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. WITEGA Laboratorien Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Omicron Biochemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Icon Isotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Medical Isotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Stable Isotope Labeled Biomolecules Value Chain
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. North America Stable Isotope Labeled Biomolecules Sales Growth Rate Forecast (2021-2026) (g)
Figure 71. North America Stable Isotope Labeled Biomolecules Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Europe Stable Isotope Labeled Biomolecules Sales Growth Rate Forecast (2021-2026) (g)
Figure 73. Europe Stable Isotope Labeled Biomolecules Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 74. Asia Pacific Stable Isotope Labeled Biomolecules Sales Growth Rate Forecast (2021-2026) (g)
Figure 75. Asia Pacific Stable Isotope Labeled Biomolecules Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 76. Latin America Stable Isotope Labeled Biomolecules Sales Growth Rate Forecast (2021-2026) (g)
Figure 77. Latin America Stable Isotope Labeled Biomolecules Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 78. Middle East and Africa Stable Isotope Labeled Biomolecules Sales Growth Rate Forecast (2021-2026) (g)
Figure 79. Middle East and Africa Stable Isotope Labeled Biomolecules Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed